AmpliTech Gr (NASDAQ:AMPG) reported quarterly sales of $5.40 million which beat the analyst consensus estimate of $4.25 million by 27.06 percent. This is a 410.88 percent increase over sales of $1.06 million the same period last year.
Jounce Therapeutics To End Proposed Business Combination With Redx Pharma Following Takeover Offer From Concentra Biosciences
Jounce Therapeutics, Inc. ("Jounce" or the "Company") and Redx Pharma plc ("Redx") have agreed to terminate their proposed business combination following the decision by Jounce's Board
